Related references
Note: Only part of the references are listed.The Many Facets of Erythropoietin Physiologic and Metabolic Response
Sukanya Suresh et al.
FRONTIERS IN PHYSIOLOGY (2020)
Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer
Ylia Salazar et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
ADAMDEC1 Maintains a Growth Factor Signaling Loop in Cancer Stem Cells
Ana Jimenez-Pascual et al.
CANCER DISCOVERY (2019)
Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells
Thuc-Nghi Duc Pham et al.
CELL DEATH & DISEASE (2019)
Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression
Yanmei Han et al.
CELL (2018)
Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells
Lintao Zhao et al.
NATURE MEDICINE (2018)
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
L. Horn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Erythroid Suppressor Cells Compromise Neonatal Immune Response against Bordetella pertussis
Garett Dunsmore et al.
JOURNAL OF IMMUNOLOGY (2017)
A pathology atlas of the human cancer transcriptome
Mathias Uhlen et al.
SCIENCE (2017)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Functional EpoR Pathway Utilization Is Not Detected in Primary Tumor Cells Isolated from Human Breast, Non-Small Cell Lung, Colorectal, and Ovarian Tumor Tissues
Scott D. Patterson et al.
PLOS ONE (2015)
Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal
Bing Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Loss of Epidermal p38α Signaling Prevents UVR-Induced Inflammation via Acute and Chronic Mechanisms
Yasuyo Sano et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer
Heinz Laubli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration
Hal E. Broxmeyer
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection
Shokrollah Elahi et al.
NATURE (2013)
Epo Receptors Are Not Detectable in Primary Human Tumor Tissue Samples
Steve Elliott et al.
PLOS ONE (2013)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Erythropoietin receptor contributes to melanoma cell survival in vivo
S. M. Kumar et al.
ONCOGENE (2012)
Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
A. Larsson et al.
BRITISH JOURNAL OF CANCER (2011)
Erythropoietin Induces Lymph Node Lymphangiogenesis and Lymph Node Tumor Metastasis
Ae Sin Lee et al.
CANCER RESEARCH (2011)
Erythropoietin Contrastingly Affects Bacterial Infection and Experimental Colitis by Inhibiting Nuclear Factor-κB-Inducible Immune Pathways
Manfred Nairz et al.
IMMUNITY (2011)
Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models
Johannes Vogel et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
Recombinant Human Erythropoietin Antagonizes Trastuzumab Treatment of Breast Cancer Cells via Jak2-Mediated Src Activation and PTEN Inactivation
Ke Liang et al.
CANCER CELL (2010)
Erythropoietin protects against diabetes through direct effects on pancreatic β cells
Diana Choi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Innate Immune Activation during Salmonella Infection Initiates Extramedullary Erythropoiesis and Splenomegaly
Amy Jackson et al.
JOURNAL OF IMMUNOLOGY (2010)
Diminished Hematopoietic Activity Associated with Alterations in Innate and Adaptive Immunity in a Mouse Model of Human Monocytic Ehrlichiosis
Katherine C. MacNamara et al.
INFECTION AND IMMUNITY (2009)
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
Julia Bohlius et al.
LANCET (2009)
Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma
SY Lai et al.
ONCOGENE (2005)
Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study
B Leyland-Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Targeted disruption of the 2B4 gene in mice reveals an in vivo role of 2B4 (CD244) in the rejection of B16 melanoma cells
SV Vaidya et al.
JOURNAL OF IMMUNOLOGY (2005)
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:: randomised, double-blind, placebo-controlled trial
M Henke et al.
LANCET (2003)
Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis
P Villa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades
M Digicaylioglu et al.
NATURE (2001)
Share Paper
